颜赞友,张 帆

血管内皮细胞与许多生理和病理过程密切相关。在血管内皮细胞损伤机制的研究中，建立合理的体外内皮细胞损伤模型是研究血管内皮损伤相关疾病的关键环节。近年来，大量研究发现中药干预血管内皮细胞损伤具有广阔的前景。本文就不同损伤因素建立血管内皮细胞损伤模型的分子机制及相关中药干预研究进行综述。

血管内皮细胞；损伤模型；分子机制；中药；综述

[1] Krüger-Genge A, Blocki A, Franke RP, Jung F. Vascular Endothelial Cell Biology: An Update. Int J Mol Sci. 2019;20(18):4411. Published 2019 Sep 7. [2] Cong L, Yang S, Zhang Y, Cao J, Fu X. DFMG attenuates the activation of macrophages induced by co_x001e_culture with LPC_x001e_injured HUVE_x001e_12 cells via the TLR4/MyD88/NF_x001e_κB signaling pathway. Int J Mol Med. 2018;41(5):2619-2628. [3] Aoyama T, Sawamura T, Furutani Y, et al. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem J. 1999;339 ( Pt 1)(Pt 1):177-184. [4] Wang Z, Chen J, Zeng Z, et al. The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation. Mol Med. 2022;28(1):26. Published 2022 Mar 2. [5] Shamsaldeen YA, Ugur R, Benham CD, Lione LA. Diabetic dyslipidaemia is associated with alterations in eNOS, caveolin-1, and endothelial dysfunction in streptozotocin treated rats. Diabetes Metab Res Rev. 2018;34(5):e2995. [6] Yamagata K. Protective Effect of Epigallocatechin Gallate on Endothelial Disorders in Atherosclerosis. J Cardiovasc Pharmacol. 2020;75(4):292-298. [7] Lee GH, Hoang TH, Jung ES, Jung SJ, Chae SW, Chae HJ. Mulberry Extract Attenuates Endothelial Dysfunction through the Regulation of Uncoupling Endothelial Nitric Oxide Synthase in High Fat Diet Rats. Nutrients. 2019;11(5):978. Published 2019 Apr 28. [8] Kattoor AJ, Goel A, Mehta JL. LOX-1: Regulation, Signaling and Its Role in Atherosclerosis. Antioxidants (Basel). 2019;8(7):218. Published 2019 Jul 11. [9] 王妍琦,王其新.内皮型一氧化氮合酶脱偶联分子机制[J].微循环学杂志,2018,28(02):66-69. [10] Zhang Z, Pan X, Yang S, et al. miR-155 Promotes ox-LDL-Induced Autophagy in Human Umbilical Vein Endothelial Cells. Mediators Inflamm. 2017;2017:9174801. [11] Fu C, Yin D, Nie H, Sun D. Notoginsenoside R1 Protects HUVEC Against Oxidized Low Density Lipoprotein (Ox-LDL)-Induced Atherogenic Response via Down-Regulating miR-132 [retracted in: Cell Physiol Biochem. 2022 Oct 31;56(5):611]. Cell Physiol Biochem. 2018;51(4):1739-1750 [12] Zheng H, Pei Y, Zhou C, Hong P, Qian ZJ. Amelioration of atherosclerosis in ox-LDL induced HUVEC by sulfated polysaccharides from Gelidium crinale with antihypertensive activity. Int J Biol Macromol. 2023;228:671-680. [13] Bai Y, Liu X, Chen Q, Chen T, Jiang N, Guo Z. Myricetin ameliorates ox-LDL-induced HUVECs apoptosis and inflammation via lncRNA GAS5 upregulating the expression of miR-29a-3p. Sci Rep. 2021;11(1):19637. [14] Wiesinger A, Peters W, Chappell D, et al. Nanomechanics of the endothelial glycocalyx in experimental sepsis. PLoS One. 2013;8(11):e80905. Published 2013 Nov 20. [15] 张晓音,吴旻,李雨萌等. 脂多糖的效应及其机理研究进展 [J]. 动物医学进展, 2015, 36 (12): 133-136. DOI:10.16437/j.cnki.1007-5038.2015.12.028. [16] Pinho-Ribeiro FA, Zarpelon AC, Mizokami SS, et al. The citrus flavonone naringenin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-κB activation. J Nutr Biochem. 2016;33:8-14. [17] Pamukcu B, Lip GY, Shantsila E. The nuclear factor--kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb Res. 2011;128(2):117-123. [18] Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600-604. [19] Guo J, Chen W, Bao B, Zhang D, Pan J, Zhang M. Protective effect of berberine against LPS-induced endothelial cell injury via the JNK signaling pathway and autophagic mechanisms. Bioengineered. 2021;12(1):1324-1337. [20] Zhong M, Zhang X, Shi X, Zheng C. Halofuginone inhibits LPS-induced attachment of monocytes to HUVECs. Int Immunopharmacol. 2020;87:106753. [21] Deng HF, Wang S, Li L, et al. Puerarin prevents vascular endothelial injury through suppression of NFκB activation in LPS-challenged human umbilical vein endothelial cells. Biomed Pharmacother. 2018;104 [22] Kwaifa IK, Bahari H, Yong YK, Noor SM. Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications. Biomolecules. 2020;10(2):291. Published 2020 Feb 13. [23] Park WH. The effects of exogenous H2O2 on cell death, reactive oxygen species and glutathione levels in calf pulmonary artery and human umbilical vein endothelial cells. Int J Mol Med. 2013;31(2):471-476. [24] Zheng Z, Wang M, Cheng C, et al. Ginsenoside Rb1 reduces H2O2induced HUVEC dysfunction by stimulating the sirtuin1/AMPactivated protein kinase pathway. Mol Med Rep. 2020;22(1):247-256. [25] Wang L, Zhou Y, Qin Y, et al. Methylophiopogonanone B of Radix Ophiopogonis protects cells from H2O2induced apoptosis through the NADPH oxidase pathway in HUVECs. Mol Med Rep. 2019;20(4):3691-3700. [26] Wang P, Tian X, Tang J, et al. Artemisinin protects endothelial function and vasodilation from oxidative damage via activation of PI3K/Akt/eNOS pathway. Exp Gerontol. 2021;147:111270 [27] Twarda-Clapa A, Olczak A, Białkowska AM, Koziołkiewicz M. Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs. Cells. 2022;11(8):1312. Published 2022 Apr 12. [28] Zeng C, Li Y, Ma J, Niu L, Tay FR. Clinical/Translational Aspects of Advanced Glycation End-Products. Trends Endocrinol Metab. 2019;30(12):959-973. [29] Twarda-Clapa A, Olczak A, Białkowska AM, Koziołkiewicz M. Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs. Cells. 2022;11(8):1312. Published 2022 Apr 12. [30] Mao W, Fan Y, Wang X, et al. Phloretin ameliorates diabetes-induced endothelial injury through AMPKdependent anti-EndMT pathway. Pharmacol Res. 2022;179:106205. [31] Hu R, Wang MQ, Ni SH, et al. Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs. Eur J Pharmacol. 2020;867:172797. [32] Zhou Q, Cheng KW, Gong J, Li ETS, Wang M. Apigenin and its methylglyoxal-adduct inhibit advanced glycation end products-induced oxidative stress and inflammation in endothelial cells. Biochem Pharmacol. 2019;166:231- 241. [33] Jakubowski H. Homocysteine Modification in Protein Structure/Function and Human Disease. Physiol Rev. 2019;99(1):555-604. [34] Liu S, Tao J, Duan F, Li H, Tan H. HHcy Induces Pyroptosis and Atherosclerosis via the Lipid RaftMediated NOX-ROS-NLRP3 Inflammasome Pathway in apoE-/- Mice. Cells. 2022;11(15):2438. Published 2022 Aug 6 [35] Stühlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001;104(21):2569-2575. [36] Zhao Z, Liu X, Shi S, et al. Exogenous hydrogen sulfide protects from endothelial cell damage, platelet activation, and neutrophils extracellular traps formation in hyperhomocysteinemia rats. Exp Cell Res. 2018;370(2):434-443. [37] Khazaei S, Yousefi R, Alavian-Mehr MM. Aggregation and fibrillation of eye lens crystallins by homocysteinylation; implication in the eye pathological disorders. Protein J. 2012;31(8):717-727. [38] Zhang Y, Zhang Y, Tang J, et al. Oxymatrine Inhibits Homocysteine-Mediated Autophagy via MIF/mTOR Signaling in Human Umbilical Vein Endothelial Cells. Cell Physiol Biochem. 2018;45(5):1893-1903. [39] Zhou ZY, Shi WT, Zhang J, et al. Sodium tanshinone IIA sulfonate protects against hyperhomocysteineinduced vascular endothelial injury via activation of NNMT/SIRT1-mediated NRF2/HO-1 and AKT/MAPKs signaling in human umbilical vascular endothelial cells. Biomed Pharmacother. 2023;158:114137. [40] Wang XJ, Tian DC, Wang FW, et al. Astaxanthin inhibits homocysteineinduced endothelial cell dysfunction via the regulation of the reactive oxygen speciesdependent VEGFVEGFR2FAK signaling pathway. Mol Med Rep. 2019;19(6):4753-4760.

点击下载PDF